TSMHT
EDN

Thurston Springer Miller Herd & Titak’s Edenor EDN Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio EDN Stock Details EDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44K Buy
1,761
+80
+5% +$2.1K 0.02% 501
2026
Q1 		$50.5K Buy
1,681
+69
+4% +$1.95K 0.02% 531
2025
Q4 		$48.3K Buy
1,612
+514
+47% +$14.3K 0.02% 500
2025
Q3 		$17.1K Sell
1,098
-9,171
-89% -$216K 0.03% 301
2025
Q2 		$272K Buy
10,269
+4,144
+68% +$129K 0.04% 321
2025
Q1 		$187K Buy
6,125
+2,033
+50% +$73.7K 0.03% 335
2024
Q4 		$176K Buy
+4,092
New +$140K 0.04% 289

Other funds holding EDN

PCM
Ping Capital Management New York $401M AUM 32.08% 1-Year Est. Return
XAUI
XP Advisory US, Inc. Miami, Florida $183M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's EDN Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Edenor (EDN) stake by 4.8% in Q2 2026, buying an estimated $2.1K and bringing the position to 1,761 shares worth $44K. The position accounts for 0.02% of the portfolio, ranked #501.

Thurston Springer Miller Herd & Titak first reported a position in EDN in Q4 2024 and has held it in 7 quarters since. The position peaked at $272K in Q2 2025. 5 funds tracked by Wall St. Rank hold EDN as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 1,761 shares of Edenor worth $44K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak bought 80 Edenor shares in Q2 2026, an estimated $2.1K.
  • Edenor made up 0.02% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #501 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Edenor in Q4 2024 and has held it in 7 quarters since.
  • Thurston Springer Miller Herd & Titak's Edenor position peaked at $272K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Edenor as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.